Matthew Hawkins
Vermögen: 2 Mio $ am 30.09.2026
Vermögen: 2 Mio $ am 30.09.2026
Matthew Hawkins currently works at Colliers International Group, Inc., as Secretary & Senior Vice President-Legal and The Law Society of Upper Canada, as Member.
Mr. Hawkins also formerly worked at Acerus Pharmaceuticals Corp., as Secretary & Vice President-Legal Affairs.
Mr. Hawkins received his undergraduate degree from the University of Toronto and graduate degree from the University of Western Ontario.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.12.2025 | 21 982 ( 0,04 % ) | 2 Mio $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| COLLIERS INTERNATIONAL GROUP INC. | General Counsel | 01.01.2016 |
The Law Society of Upper Canada
The Law Society of Upper Canada Miscellaneous Commercial ServicesCommercial Services Operates lawyer's association | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ACERUS PHARMACEUTICALS CORPORATION | General Counsel | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Colliers International Group, Inc.
Colliers International Group, Inc. Investment ManagersFinance Provides investment management and commercial real estate professional services | Finance |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Law Society of Upper Canada
The Law Society of Upper Canada Miscellaneous Commercial ServicesCommercial Services Operates lawyer's association | Commercial Services |
Acerus Pharmaceuticals Corp.
Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen